{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T12:20:58Z","timestamp":1762950058918,"version":"3.45.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2024-00440881","2024-00440881"],"award-info":[{"award-number":["2024-00440881","2024-00440881"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"DOI":"10.1038\/s41523-025-00838-4","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T12:18:35Z","timestamp":1762949915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Haseen","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Kyung","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"838_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","volume":"32","author":"ME Lacouture","year":"2021","unstructured":"Lacouture, M. E. et al. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines(\u2606). Ann. Oncol. 32, 157\u2013170 (2021).","journal-title":"Ann. Oncol."},{"key":"838_CR2","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaad.2016.12.027","volume":"76","author":"A Fonia","year":"2017","unstructured":"Fonia, A. et al. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients. J. Am. Acad. Dermatol. 76, 948\u2013957 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"838_CR3","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/annonc\/mds095","volume":"23","author":"N Kluger","year":"2012","unstructured":"Kluger, N. et al. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. Ann. Oncol. 23, 2879\u20132884 (2012).","journal-title":"Ann. Oncol."},{"key":"838_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","volume":"24","author":"D Kang","year":"2019","unstructured":"Kang, D. et al. Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study. Oncologist 24, 414\u2013420 (2019).","journal-title":"Oncologist"},{"key":"838_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/NCC.0000000000001234","volume":"47","author":"M Contreras Molina","year":"2024","unstructured":"Contreras Molina, M. et al. Effectiveness of scalp cooling to prevent chemotherapy-induced alopecia in patients undergoing breast cancer treatment: a systematic review and meta-analysis. Cancer Nurs. 47, 319\u2013326 (2024).","journal-title":"Cancer Nurs."},{"key":"838_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fonc.2019.00733","volume":"9","author":"T Kinoshita","year":"2019","unstructured":"Kinoshita, T. et al. Efficacy of scalp cooling in preventing and recovering from chemotherapy-induced alopecia in breast cancer patients: the HOPE study. Front. Oncol. 9, 733 (2019).","journal-title":"Front. Oncol."},{"key":"838_CR7","first-page":"6119","volume":"29","author":"S Ohsumi","year":"2021","unstructured":"Ohsumi, S. et al. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients. Support Care Cancer 29, 6119\u20136125 (2021).","journal-title":"Support Care Cancer"},{"key":"838_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-018-4983-8","volume":"173","author":"K Smetanay","year":"2019","unstructured":"Smetanay, K. et al. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res. Treat. 173, 135\u2013143 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1200\/JCO.23.02374","volume":"42","author":"D Kang","year":"2024","unstructured":"Kang, D. et al. Scalp cooling in preventing persistent chemotherapy-induced alopecia: a randomized controlled trial. J. Clin. Oncol. 42, 3115\u20133122 (2024).","journal-title":"J. Clin. Oncol."},{"key":"838_CR10","doi-asserted-by":"crossref","unstructured":"Kang, D. et al. Scalp cooling for preventing persistent chemotherapy-induced alopecia in anthracycline-treated patients: a single-arm trial. J. Am. Acad. Dermatol. 93, 1122-1124 (2025).","DOI":"10.1016\/j.jaad.2025.06.023"},{"key":"838_CR11","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamadermatol.2021.3676","volume":"157","author":"B Bhoyrul","year":"2021","unstructured":"Bhoyrul, B. et al. Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors. JAMA Dermatol. 157, 1335\u20131342 (2021).","journal-title":"JAMA Dermatol."},{"key":"838_CR12","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.csbj.2024.06.026","volume":"23","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Application of multi-omics techniques to androgenetic alopecia: current status and perspectives. Comput. Struct. Biotechnol. J. 23, 2623\u20132636 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.228","volume":"40","author":"AM Hillmer","year":"2008","unstructured":"Hillmer, A. M. et al. Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat. Genet. 40, 1279\u20131281 (2008).","journal-title":"Nat. Genet."},{"key":"838_CR14","first-page":"1437","volume":"9","author":"S Martinkovich","year":"2014","unstructured":"Martinkovich, S., Shah, D., Planey, S. L. & Arnott, J. A. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin. Inter. Aging 9, 1437\u20131452 (2014).","journal-title":"Clin. Inter. Aging"},{"key":"838_CR15","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1111\/jocd.12888","volume":"18","author":"ED Lephart","year":"2019","unstructured":"Lephart, E. D. Human scalp hair: modulation by various factors and hormones do estrogens inhibit or stimulate-A perplexing perspective. J. Cosmet. Dermatol. 18, 1860\u20131865 (2019).","journal-title":"J. Cosmet. Dermatol."},{"key":"838_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/bjd.12716","volume":"170","author":"V Kanti","year":"2014","unstructured":"Kanti, V. et al. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study. Br. J. Dermatol. 170, 643\u2013650 (2014).","journal-title":"Br. J. Dermatol."},{"key":"838_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2216-3","volume":"5","author":"F Karatas","year":"2016","unstructured":"Karatas, F., Sahin, S., Sever, A. R. & Altundag, K. Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview. SpringerPlus 5, 585 (2016).","journal-title":"SpringerPlus"},{"key":"838_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/sj.bjc.6602688","volume":"93","author":"R Carpenter","year":"2005","unstructured":"Carpenter, R. & Miller, W. R. Role of aromatase inhibitors in breast cancer. Br. J. Cancer 93, S1\u2013S5 (2005).","journal-title":"Br. J. Cancer"},{"key":"838_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ijwd.2021.07.002","volume":"7","author":"S Behbahani","year":"2021","unstructured":"Behbahani, S. et al. Art of prevention: the importance of dermatologic care when using aromatase inhibitors. Int. J. Women\u2019s Dermatol. 7, 769\u2013773 (2021).","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"838_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fonc.2019.00943","volume":"9","author":"M Huerta-Reyes","year":"2019","unstructured":"Huerta-Reyes, M. et al. Treatment of breast cancer with gonadotropin-releasing hormone analogs. Front Oncol. 9, 943 (2019).","journal-title":"Front Oncol."},{"key":"838_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jdrv.2024.09.004","volume":"2","author":"SM Perez","year":"2024","unstructured":"Perez, S. M., Williams, K. N., Nguyen, B. & Tosti, A. Drugs and androgenetic alopecia: what to look out for. JAAD Rev. 2, 81\u201387 (2024).","journal-title":"JAAD Rev."},{"key":"838_CR22","doi-asserted-by":"publisher","first-page":"4931852","DOI":"10.1155\/2018\/4931852","volume":"2018","author":"N Kojima","year":"2018","unstructured":"Kojima, N., Yamasaki, Y., Koh, H., Miyashita, M. & Morita, H. Long-acting luteinizing hormone-releasing hormone agonist for ovarian hyperstimulation induced by tamoxifen for breast cancer. Case Rep. Obstet. Gynecol. 2018, 4931852 (2018).","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"838_CR23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","volume":"154","author":"A Freites-Martinez","year":"2018","unstructured":"Freites-Martinez, A. et al. Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol. 154, 670\u2013675 (2018).","journal-title":"JAMA Dermatol."},{"key":"838_CR24","doi-asserted-by":"crossref","unstructured":"Valerio, M. R. et al. Real-world analysis of adherence to abemaciclib and endocrine therapy in women with HR+\/HER2- breast cancer. Biomedicines 13, 546 (2025).","DOI":"10.3390\/biomedicines13030546"},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/onco.13690","volume":"26","author":"A Dilawari","year":"2021","unstructured":"Dilawari, A. et al. Does scalp cooling have the same efficacy in black patients receiving chemotherapy for breast cancer? Oncologist 26, 292\u2013e548 (2021).","journal-title":"Oncologist"},{"key":"838_CR26","first-page":"13","volume":"13","author":"P Masidonski","year":"2009","unstructured":"Masidonski, P. & Mahon, S. M. Permanent alopecia in women being treated for breast cancer. Clin. J. Oncol. Nurs. 13, 13\u201314 (2009).","journal-title":"Clin. J. Oncol. Nurs."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-025-00838-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-025-00838-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-025-00838-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T12:18:39Z","timestamp":1762949919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-025-00838-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1038\/s41523-025-00838-4","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}